NCT07519369

Brief Summary

Children with autism spectrum disorder (ASD) often show motor abnormalities and sleep disturbances that affect behavior, learning, and family quality of life. Emerging technologies such as wearable devices and markerless systems provide accessible tools for gait and sleep assessment, with actigraphy recommended for long-term monitoring in natural settings. Evidence also suggests links between sleep problems and sensory processing differences. This project, aims to integrate these approaches in a clinical-translational framework.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 18, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 2, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 9, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Completed
Last Updated

April 9, 2026

Status Verified

March 1, 2026

Enrollment Period

3 months

First QC Date

April 2, 2026

Last Update Submit

April 2, 2026

Conditions

Keywords

Autism Spectrum DisorderASDsleepmovement disorders

Outcome Measures

Primary Outcomes (1)

  • Feasibility and adherence to continuous use of a wearable sensor in children with autism spectrum disorder (ASD)

    This objective aims to assess the feasibility and adherence to continuous use of a wearable sensor in children with autism spectrum disorder (ASD), evaluating tolerability, compliance, and data quality in real-life conditions over a 7-day monitoring period. Feasibility is primarily defined as the proportion of participants completing the protocol with valid data, while adherence is assessed through wear time, data completeness, and caregiver-reported acceptability.

    7 days

Secondary Outcomes (3)

  • Gait Pattern

    during the enrollment period with wearable sensor

  • ASD subgroups

    during the enrollment period using the wearable sensor

  • Daily activity and sleep quality

    during the enrollment period using a wearable sensor

Study Arms (2)

ASD patient cohort

EXPERIMENTAL
Device: placement of a wearable wrist sensor

cohort of healthy controls

ACTIVE COMPARATOR
Device: placement of a wearable wrist sensor

Interventions

The project integrates three complementary modules on the same participant: (A) monitoring with wearable sensors (primary objective), (B) laboratory-based gait analysis, and (C) sleep assessment using home video-EEG polysomnography (PSG). The reference wearable instrumentation follows the technical protocols established by the Politecnico di Milano, which already include the use of the AX6 device and F-Scan GO insoles among the wearable devices available within the research program.

Also known as: polysomnography, gait analysis
ASD patient cohortcohort of healthy controls

Eligibility Criteria

Age2 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Diagnosis of autism spectrum disorder (ASD) according to DSM-5 criteria
  • Age between 2 and 18 years
  • Ability to walk independently
  • Willingness to wear a wearable device (wrist sensor) continuously for 7 days and pedobarographic insoles for reproducible gait monitoring
  • Willingness to undergo one night of home polysomnography with video-EEG/polygraphy during the wearable monitoring period
  • Informed consent signed by both parents/legal guardian; assent from the minor when applicable

You may not qualify if:

  • Skin contraindications to the wristband/fixation systems (known material allergies, active wrist dermatitis, or skin lesions preventing prolonged use)
  • Severe motor impairments
  • Recent orthopedic surgery (\<6 months)
  • Use of orthoses or assistive devices during walking
  • Severe behavioral disorder making device use impracticable despite acclimatization strategies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS San Raffaele

Roma, RM, 00163, Italy

RECRUITING

MeSH Terms

Conditions

Autism Spectrum DisorderMovement Disorders

Interventions

PolysomnographyGait Analysis

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental DisordersCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Monitoring, PhysiologicDiagnostic Techniques and ProceduresDiagnosisGaitPhysical ExaminationPhysical Functional PerformancePhysical FitnessHealthPopulation Characteristics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: This study examines motor activity and sleep patterns in children and adolescents with autism spectrum disorder (ASD) using a multimodal, non-invasive approach. It includes: (A) continuous monitoring with wearable sensors, (B) laboratory gait analysis, and (C) home video-EEG polysomnography (PSG), with a control group. Participants aged 2-18 years complete a standardized protocol. At baseline, clinical data are collected, wearable devices (AX6 wrist sensor and F-Scan GO insoles) are applied, and gait is assessed using both marker-based and AI markerless systems. Sensory processing is evaluated with the Sensory Profile 2. Over a 7-day home phase, devices record daily activity and sleep-wake patterns. Sleep is also assessed with 1-2 nights of home PSG, allowing comparison with wearable data. At follow-up, devices are returned, data are checked, and caregiver feedback is collected. The study evaluates feasibility and explores links between movement, sleep, and sensory processing.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 2, 2026

First Posted

April 9, 2026

Study Start

February 18, 2026

Primary Completion

June 1, 2026

Study Completion

June 1, 2026

Last Updated

April 9, 2026

Record last verified: 2026-03

Locations